New York, NY, March 03, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular damage response pathways, reported that Lisa Ricciardi and James O’Brien, Cognition’s chief executive and chief financial officers, would be making a company presentation at the annual H.C. Wainwright Global Life Sciences Conference.

Read the original here:
Cognition Therapeutics to Present Corporate and Clinical Update at H.C. Wainwright Global Life Sciences Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *